GHK-CU BASIC 10 MG

Dragon Pharma GHK-Cu Basic 10 mg – Copper Peptide for Tissue Regeneration Research

Dragon Pharma GHK-Cu Basic 10 mg is a copper-binding tripeptide with the amino acid sequence Gly-His-Lys (GHK). This naturally occurring peptide has been extensively investigated in research for its role in tissue regeneration, wound healing, and skin repair mechanisms. The basic form of GHK-Cu offers researchers a stable and well-characterized compound for investigating copper-dependent biological processes.

Each vial contains 10 mg of lyophilized GHK-Cu Basic in a 2 mL format, requiring reconstitution with bacteriostatic water before use. GHK-Cu is known for its ability to modulate various cellular processes, including collagen production, angiogenesis, and inflammation, making it a valuable tool in regenerative medicine research. For related research compounds, explore our peptides category and specifically BPC 157 for additional wound healing research applications.

What Makes GHK-Cu Basic Valuable in Research?

GHK-Cu represents a copper-peptide complex that has demonstrated significant biological activity in preclinical research. The tripeptide GHK naturally occurs in human plasma and is known to have multiple biological functions, including stimulation of collagen synthesis, promotion of angiogenesis, and modulation of inflammatory responses. The basic form of GHK-Cu provides researchers with a consistent and reliable compound for investigating these mechanisms.

Researchers value GHK-Cu for its broad range of biological activities and its potential applications in wound healing, skin regeneration, and tissue repair studies. Its copper-binding properties add another dimension to its biological activity, as copper is an essential cofactor for many enzymes involved in tissue remodeling. For investigators exploring other regenerative peptides, TB 500 offers complementary research avenues in angiogenesis and tissue repair.

Current scientific literature on GHK-Cu can be accessed through the PubMed database, where researchers can review peer-reviewed studies on its biological activity and experimental applications.

Key Research Applications for Dragon Pharma GHK-Cu Basic

• ✔ Investigation of wound healing mechanisms
• ✔ Evaluation of collagen synthesis and tissue remodeling
• ✔ Research on angiogenesis and vascular regeneration
• ✔ Studies of anti-inflammatory and antioxidant effects
• ✔ Preclinical models of skin and tissue repair

Product Details

Dosage & Usage Guidelines

Reconstitution Protocol

• ✔ Use sterile bacteriostatic water for injection
• ✔ Add appropriate volume to achieve desired concentration
• ✔ Swirl gently to dissolve – do not shake vigorously
• ✔ Store reconstituted solution at 2–8°C

Reconstitute the lyophilized powder using bacteriostatic water to a concentration suitable for your research protocol. The 10 mg format allows for flexible dosing across a range of experimental models. Always use aseptic technique during preparation to maintain peptide integrity.

Typical Research Parameters

In research settings, GHK-Cu Basic is typically administered via subcutaneous or topical application. Dosing schedules and concentrations vary widely depending on the experimental design, animal model, and specific research objectives.

• ✔ Commonly used in wound healing and skin repair studies
• ✔ Often combined with histological and molecular analysis
• ✔ Used to investigate collagen synthesis and angiogenesis
• ✔ Research models include cutaneous wounds and tissue regeneration paradigms

Factors to Consider in Research Protocols

• Copper-binding properties require careful preparation and storage
• Reconstitution stability is limited; prepare fresh solutions for each use
• Individual variation in response may be observed across subjects
• Storage conditions significantly impact peptide stability

Lab Testing & Batch Transparency

Lab status

COA pending release

Third-party analytical testing (COA) for Dragon Pharma GHK-Cu Basic 10 mg is currently not yet available. Batch-specific assay data, purity analysis, and verification documentation will be published once released.

Testing Status

Pending

COA Availability

Not yet published

Batch Verification

In progress

Update

Coming soon

Transparency note: Dragon Pharma publishes batch-specific lab reports once analytical testing is completed and verified.

Awaiting COA

Shipping & Product Authenticity

What to Expect

• ✔ Orders are processed after payment confirmation
• ✔ USA Domestic shipping is typically faster when local stock is selected
• ✔ International orders include tracking, though update frequency may vary by destination
• ✔ Multiple warehouses may result in separate shipments when applicable

For complete delivery details, tracking policy, and reshipment terms, please see our Shipping Info page.

Storage

Store the lyophilized powder at controlled room temperature (15–25°C) in a dry, dark place, away from direct light and moisture. The unopened vial should be kept in its original packaging to maintain stability.

After reconstitution, store the solution at 2–8°C and use within 14 days. Do not freeze. Discard any unused portion after the recommended storage period. Before use, inspect the solution and avoid use if it appears cloudy, discolored, or contains particulate matter, or if the vial or seal is compromised.

Keep out of reach of children. Follow proper handling and sterile injection practices during research use.

Proper storage conditions help maintain product stability and consistent performance across the product's shelf life.

Frequently Asked Questions